期刊文献+

Regression of hepatocellular carcinoma during vitamin K administration

Regression of hepatocellular carcinoma during vitamin K administration
下载PDF
导出
摘要 An 85-year-old man with HCV infection and diabetes mellitus was diagnosed as having hepatocellular carcinoma (HCC, 13 cm in diameter) based on high serum alpha-fetoprotein (AFP), AFP-L3, and des-y-carboxy prothrombin levels as well as typical enhancement pattern on contrast-enhanced CT. The patient did not receive any interventional treatments because of advanced age and the advanced stage of HCC. He chose to take vitamin K, which was reported to suppress the growth of HCC in vitro. Three months after starting vitamin K, all three tumor markers were normalized and HCC was markedly regressed, showing no enhancement in the early arterial phase on CT. Here we present the report describing the regression of HCC during the administration of vitamin K. An 85-year-old man with HCV infection and diabetes mellitus was diagnosed as having hepatocellular carcinoma (HCC, 13 cm in diameter) based on high serum alpha-fetoprotein (AFP),AFP-L3,and des-γ-carboxy prothrombin levels as well as typical enhancement pattern on contrast-enhanced CT. The patient did not receive any interventional treatments because of advanced age and the advanced stage of HCC.He chose to take vitamin K,which was reported to suppress the growth of HCC in vitro. Three months after starting vitamin K, all three tumor markers were normalized and HCC was markedly regressed, showing no enhancement in the early arterial phase on CT. Here we present the report describing the regression of HCC during the administration of vitamin K.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第42期6722-6724,共3页 世界胃肠病学杂志(英文版)
关键词 Hepatocellular carcinoma Vitamin K Regression 肝细胞癌 维生素K 病理机制 临床表现
  • 相关文献

参考文献15

  • 1[1]Llovet JM,Burroughs A,Bruix J.Hepatocellular carcinoma.Lancet 2003; 362:1907-1917
  • 2[2]Leung TW,Johnson PJ.Systemic therapy for hepatocellular carcinoma.Semin Oncol 2001; 28:514-520
  • 3[3]Anthony PP.Hepatocellular carcinoma:an overview.Histopathology 2001; 39:109-118
  • 4[4]Lamson DW,Plaza SM.The anticancer effects of vitamin K.Altern Med Rev 2003; 8:303-318
  • 5[5]Wang Z,Wang M,Finn F,Carr BI.The growth inhibitory effects of vitamins K and their actions on gene expression.Hepatology 1995; 22:876-882
  • 6[6]Yaguchi M,Miyazawa K,Otawa M,Katagiri T,Nishimaki J,Uchida Y,Iwase O,Gotoh A.Kawanishi Y,Toyama K.Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome:flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody.Leukemia1998; 12:1392-1397
  • 7[7]Nishimaki J,Miyazawa K,Yaguchi M,Katagiri T,Kawanishi Y,Toyama K,Ohyashiki K,Hashimoto S,Nakaya K,Takiguchi T.Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation.Leukemia 1999; 13:1399-1405
  • 8[8]Miyazawa K,Nishimaki J,Ohyashiki K,Enomoto S,Kuriya S,Fukuda R,Hotta T,Teramura M,Mizoguchi H,Uchiyama T.Omine M.Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia:information through a questionnaire survey of multi-center pilot studies in Japan.Leukemia 2000; 14:1156-1157
  • 9[9]WH C.Efforts to explain spontaneous regression of cancer.J Surg Oncol 1981;.17:201-209
  • 10[10]Lin TJ,Liao LY,Lin CL,Shih LS,Chang TA,Tu HY,Chen RC,Wang CS.Spontaneous regression of hepatocellular carcinoma:a case report and literature review.Hepatogastroenterology 2004;51:579-582

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部